Consequences of preeclampsia for the newborn: role of oxidative stress

References

• Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working group on research on hypertension during pregnancy. Hypertension41, 437–445 (2003).
   PubMed Web of Science ®Google Scholar
• Raijmakers MT, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension44, 374–380 (2004).
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science308, 1592–1594 (2005).
   PubMed Web of Science ®Google Scholar
• Oudejans CBM, van Dijk M, Oosterkamp M, Lachmeijer A, Blankenstein MA. Genetics of preeclampsia. Paradigm shifts. Hum. Genet.120, 607–612 (2007).
   PubMed Web of Science ®Google Scholar
• Hafner E, Metzenbauer M, Hofinger D et al. Placental growth from the first to the second trimester of pregnancy in SGA-foetuses and pre-eclamptic pregnancies compared to normal foetuses. Placenta24, 336–342 (2003).
   PubMed Web of Science ®Google Scholar
• Martinez-Orgado J, Gonzalez R, Tovar S, Marin J, Salaices M, Alonso MJ. Administration of N(ω)-L-arginine methyl ester (L-NAME) impairs endothelium-dependent relaxation in gravid but not nongravid rats. J. Soc. Gynecol. Investig.10, 74–81 (2003).
   PubMedGoogle Scholar
• Zeeman GG, Dekker GA. Pathogenesis of preeclampsia. A hypothesis. Clin. Obstet. Gynecol.35, 317–337 (1992).
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet365, 785–799 (2005).
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum. Reprod. Update12, 747–755 (2006).
   PubMed Web of Science ®Google Scholar
• Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol.16, 1200–1204 (1989).
   Google Scholar
• Myatt L. Placental adaptive responses and fetal programming. J. Physiol.572, 25–30 (2006).
   PubMed Web of Science ®Google Scholar
• Perkins AV. Endogenous anti-oxidants in pregnancy and preeclampsia. Aust. NZ. J. Obstet. Gynaecol.46, 77–83 (2006).
   PubMed Web of Science ®Google Scholar
• Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet. Gynecol. Surv.60, 807–816 (2005).
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y. Secretion of lipid peroxides by the human placenta. Am. J. Obstet. Gynecol.169, 1462–1466 (1993).
   PubMed Web of Science ®Google Scholar
• Moretti M, Phillips M, Abouzeid A, Cataneo RN, Greenberg J. Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia. Am. J. Obstet. Gynecol.190, 1184–1190 (2004).
   PubMed Web of Science ®Google Scholar
• Bonet B, Chait A, Gown AM, Knopp RH. Metabolism of modified LDL by cultured human placental cells. Atherosclerosis112, 125–136 (1995).
   PubMedGoogle Scholar
• Chamy VM, Lepe J, Catalan A, Retamal D, Escobar JA, Madrid EM. Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol. Res.39, 229–236 (2006).
   PubMed Web of Science ®Google Scholar
• Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-κB and upregulate ICAM-1 in vascular endothelial cells. FASEB J.15, 279–281 (2001).
   PubMed Web of Science ®Google Scholar
• Uotila J, Tuimala R, Pyykko K, Ahotupa M. Pregnancy-induced hypertension is associated with changes in maternal and umbilical blood antioxidants. Gynecol. Obstet. Invest.36, 153–157 (1993).
   PubMed Web of Science ®Google Scholar
• Barden A, Ritchie J, Walters B et al. Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia. Hypertension38, 803–808 (2001).
   PubMed Web of Science ®Google Scholar
• Bonet B, Hauge-Gillenwater H, Zhu XD, Knopp RH. LDL oxidation and human placental trophoblast and macrophage cytotoxicity. Proc. Soc. Exp. Biol. Med.217, 203–211 (1998).
   PubMed Web of Science ®Google Scholar
• Staff AC, Ranheim T, Henriksen T, Halvorsen B. 8-iso-prostaglandin f(2α) reduces trophoblast invasion and matrix metalloproteinase activity. Hypertension35, 1307–1313 (2000).
   PubMedGoogle Scholar
• Walsh SW, Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J. Clin. Endocrinol. Metab.80, 1888–1893 (1995).
   PubMed Web of Science ®Google Scholar
• Walsh SW, Vaughan JE, Wang Y, Roberts LJ. Placental isoprostane is significantly increased in preeclampsia. FASEB J.14, 1289–1296 (2000).
   PubMed Web of Science ®Google Scholar
• Wang Y, Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta19, 581–586 (1998).
   PubMed Web of Science ®Google Scholar
• Poranen AK, Ekblad U, Uotila P, Ahotupa M. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta17, 401–405 (1996).
   PubMed Web of Science ®Google Scholar
• Cooke CL, Davidge ST. Endothelial-dependent vasodilation is reduced in mesenteric arteries from superoxide dismutase knockout mice. Cardiovasc. Res.60, 635–642 (2003).
   PubMedGoogle Scholar
• Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J. Soc. Gynecol. Investig.3, 179–184 (1996).
   PubMedGoogle Scholar
• Wang Y, Walsh SW. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta22, 206–212 (2001).
   PubMed Web of Science ®Google Scholar
• Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension28, 488–493 (1996).
   PubMed Web of Science ®Google Scholar
• Myatt L, Eis AL, Brockman DE, Greer IA, Lyall F. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum. Reprod.12, 167–172 (1997).
   PubMed Web of Science ®Google Scholar
• Steinert JR, Wyatt AW, Poston L, Jacob R, Mann GE. Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal venous endothelial cells. FASEB J.16, 721–723 (2002).
   PubMed Web of Science ®Google Scholar
• Parra MC, Lees C, Mann GE, Pearson JD, Nicolaides KH. Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia. Am. J. Obstet. Gynecol.184, 497–502 (2001).
   PubMed Web of Science ®Google Scholar
• Kossenjans W, Eis A, Sahay R, Brockman D, Myatt L. Role of peroxynitrite in altered fetal–placental vascular reactivity in diabetes or preeclampsia. Am. J. Physiol. Heart Circ. Physiol.278, H1311–H1319 (2000).
   Web of Science ®Google Scholar
• Husain K, Hazelrigg SR. Oxidative injury due to chronic nitric oxide synthase inhibition in rat. Effect of regular exercise on the heart. Biochim. Biophys. Acta1587, 75–82 (2002).
   PubMed Web of Science ®Google Scholar
• Impey L, Greenwood C, Sheil O, MacQuillan K, Reynolds M, Redman C. The relation between pre-eclampsia at term and neonatal encephalopathy. Arch. Dis. Child Fetal Neonatal Med.85, F170–F172 (2001).
   Web of Science ®Google Scholar
• Mellembakken JR, Aukrust P, Hestdal K, Ueland T, Abyholm T, Videm V. Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension38, 394–398 (2001).
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y, Jesse R. Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane. Am. J. Obstet. Gynecol.169, 1007–1012 (1993).
   PubMed Web of Science ®Google Scholar
• Davidge ST, Signorella AP, Hubel CA, Lykins DL, Roberts JM. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension28, 758–764 (1996).
   PubMed Web of Science ®Google Scholar
• Rumbold A, Duley L, Crowther C, Haslam R. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst. Rev.CD004227 (2005).
   Google Scholar
• Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet367, 1145–1154 (2006).
   PubMed Web of Science ®Google Scholar
• Paruk F, Moodley J. Maternal and neonatal outcome in early- and late-onset pre-eclampsia. Semin. Neonatol.5, 197–207 (2000).
   PubMedGoogle Scholar
• Martínez-Orgado J, Saéz-Pérez E, García-Aparicio J. Fisiopatología y clínica del hijo de madre hipertensa. Pediatrika11, 39–46 (1991).
   Google Scholar
• Martínez-Orgado J, Guardia-Nieto L, Cueto E, Lozano-Maneiro L, Martínez MC, Torres-Martí J. Influencia del estado hipertensivo del embarazo en la aparición de complicaciones neonatales. Rev. Esp. Pediatr.54, 379–385 (1998).
   Google Scholar
• Brazy JE, Grimm JK, Little VA. Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J. Pediatr.100, 265–271 (1982).
   PubMed Web of Science ®Google Scholar
• Martikainen AM, Heinonen KM, Saarikoski SV. The effect of hypertension in pregnancy on fetal and neonatal condition. Int. J. Gynaecol. Obstet.30, 213–220 (1989).
   PubMed Web of Science ®Google Scholar
• Martikainen MA, Airaksinen EM, Heinonen KM, Castren ML. The neurological condition of the newborn infant with maternal hypertension, examined at term. Early Hum. Dev.16, 107–118 (1988).
   PubMed Web of Science ®Google Scholar
• Doron MW, Makhlouf RA, Katz VL, Lawson EE, Stiles AD. Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia. J. Pediatr.125, 452–458 (1994).
   PubMed Web of Science ®Google Scholar
• Withagen MI, Wallenburg HC, Steegers EA, Hop WC, Visser W. Morbidity and development in childhood of infants born after temporising treatment of early onset pre-eclampsia. Br. J. Obstet. Gynaecol.112, 910–914 (2005).
   Google Scholar
• Badawi N, Kurinczuk JJ, Keogh JM et al. Antepartum risk factors for newborn encephalopathy. The Western Australian case–control study. Br. Med. J.317, 1549–1553 (1998).
   PubMed Web of Science ®Google Scholar
• Mutch LM, Moar VA, Ounsted MK, Redman CW. Hypertension during pregnancy, with and without specific hypotensive treatment. II. The growth and development of the infant in the first year of life. Early Hum. Dev.1, 59–67 (1977).
   PubMed Web of Science ®Google Scholar
• Martínez-Orgado J, Saéz-Pérez E, Clot-Bru C, García-Aparicio J. Riesgo de afectación neurológica en el hijo de madre hipertensa: evaluación al año de vida. Rev. Esp. Pediatr.50, 103–107 (1994).
   Google Scholar
• Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br. Med. J.298, 564–567 (1989).
   PubMed Web of Science ®Google Scholar
• Pinto A, Sorrentino R, Sorrentino P et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am. J. Obstet. Gynecol.164, 507–513 (1991).
   PubMed Web of Science ®Google Scholar
• Steinert JR, Poston L, Mann GE, Jacob R. Abnormalities in intracellular Ca2+ regulation in fetal vascular smooth muscle in pre-eclampsia. Enhanced sensitivity to arachidonic acid. FASEB J.17, 307–309 (2003).
   PubMedGoogle Scholar
• Esplin MS, Fausett MB, Fraser A et al. Paternal and maternal components of the predisposition to preeclampsia. N. Engl. J. Med.344, 867–872 (2001).
   PubMed Web of Science ®Google Scholar
• Davidge ST, Signorella AP, Lykins DL, Gilmour CH, Roberts JM. Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am. J. Obstet. Gynecol.175, 1301–1306 (1996).
   PubMed Web of Science ®Google Scholar
• Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am. J. Obstet. Gynecol.173, 714–718 (1995).
   PubMed Web of Science ®Google Scholar
• Norris LA, Higgins JR, Darling MR, Walshe JJ, Bonnar J. Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia. Obstet. Gynecol.93, 958–963 (1999).
   PubMed Web of Science ®Google Scholar
• Jouppila P, Kirkinen P. Blood velocity waveforms of the fetal aorta in normal and hypertensive pregnancies. Obstet. Gynecol.67, 856–860 (1986).
   PubMed Web of Science ®Google Scholar
• Arias F. Accuracy of the middle-cerebral-to-umbilical-artery resistance index ratio in the prediction of neonatal outcome in patients at high risk for fetal and neonatal complications. Am. J. Obstet. Gynecol.171, 1541–1545 (1994).
   PubMed Web of Science ®Google Scholar
• Martínez-Orgado J, Gonzalez R, Alonso MJ, Salaices M. Impairment of fetal endothelium-dependent relaxation in a rat model of preeclampsia by chronic nitric oxide synthase inhibition. J. Soc. Gynecol. Investig.11, 82–88 (2004).
   PubMedGoogle Scholar
• Green J, Assady S, Nakhoul F, Bick T, Jakobi P, Abassi Z. Differential effects of sera from normotensive and hypertensive pregnant women on Ca(2+) metabolism in normal vasular smooth muscle cells. J. Am. Soc. Nephrol.11, 1188–1198 (2000).
   PubMedGoogle Scholar
• Martínez-Orgado J, Lozano-Maneiro L, Guardia-Nieto L, Torres-Martí J, Saéz-Pérez E. Puntuación de riesgo neonatal: una herramienta útil en la predicción de complicaciones del hijo de madre hipertensa. An. Esp. Pediatr.43, 277–282 (1995).
   Google Scholar
• Martinez-Orgado J, Saéz-Pérez E, García-Aparicio J. Predicción de complicaciones en el hijo de madre hipertensa. An. Esp. Pediatr.35, 233–237 (1991).
   PubMedGoogle Scholar
• Gu Y, Lewis DF, Zhang Y, Groome LJ, Wang Y. Increased superoxide generation and decreased stress protein Hsp90 expression in human umbilical cord vein endothelial cells (HUVECs) from pregnancies complicated by preeclampsia. Hypertens. Pregnancy25, 169–182 (2006).
   PubMed Web of Science ®Google Scholar
• Tastekin A, Ors R, Demircan B, Saricam Z, Ingec M, Akcay F. Oxidative stress in infants born to preeclamptic mothers. Pediatr. Int.47, 658–662 (2005).
   PubMed Web of Science ®Google Scholar
• Kato H, Yoneyama Y, Araki T. Fetal plasma lipid peroxide levels in pregnancies complicated by preeclampsia. Gynecol. Obstet. Invest.43, 158–161 (1997).
   PubMedGoogle Scholar
• Braekke K, Harsem NK, Staff AC. Oxidative stress and antioxidant status in fetal circulation in preeclampsia. Pediatr. Res.60, 560–564 (2006).
   PubMed Web of Science ®Google Scholar